Real-time enrollment status for this lupus nephritis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06064929 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Lupus Nephritis |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 15 sites in the US |
| Sponsor | HI-Bio, A Biogen Company |
| Last Updated on CT.gov | December 31, 2025 (Dec 31, 2025) |
As of March 2, 2026: Clinical trial NCT06064929 is currently active_not_recruiting participants. This clinical trial study for lupus nephritis is not currently accepting new participants at 15 locations across the United States. The study is sponsored by HI-Bio, A Biogen Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06064929 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06064929 was last updated Dec 31, 2025 (December 31, 2025). HelloStudys verifies this status automatically.